OBJECTIVES: The aim of this study was to investigate for the first time the association between body fat and risk of amyotrophic lateral sclerosis (ALS) with an appropriate prospective study design. METHODS: The EPIC (European Prospective Investigation into Cancer and Nutrition) study included 518,108 individuals recruited from the general population across 10 Western European countries. At recruitment, information on lifestyle was collected and anthropometric characteristics were measured. Cox hazard models were fitted to investigate the associations between anthropometric measures and ALS mortality. RESULTS: Two hundred twenty-two ALS deaths (79 men and 143 women) occurred during the follow-up period (mean follow-up = 13 years). There was a statistically significant interaction between categories of body mass index and sex regarding ALS risk (p = 0.009): in men, a significant linear decrease of risk per unit of body mass index was observed (hazard ratio = 0.93, 95% confidence interval 0.86-0.99 per kg/m(2)); among women, the risk was more than 3-fold increased for underweight compared with normal-weight women. Among women, a significant risk reduction increasing the waist/hip ratio was also evident: women in the top quartile had less than half the risk of ALS compared with those in the bottom quartile (hazard ratio = 0.48, 95% confidence interval 0.25-0.93) with a borderline significant p value for trend across quartiles (p = 0.056). CONCLUSION: Increased prediagnostic body fat is associated with a decreased risk of ALS mortality.
OBJECTIVES: The aim of this study was to investigate for the first time the association between body fat and risk of amyotrophic lateral sclerosis (ALS) with an appropriate prospective study design. METHODS: The EPIC (European Prospective Investigation into Cancer and Nutrition) study included 518,108 individuals recruited from the general population across 10 Western European countries. At recruitment, information on lifestyle was collected and anthropometric characteristics were measured. Cox hazard models were fitted to investigate the associations between anthropometric measures and ALS mortality. RESULTS: Two hundred twenty-two ALS deaths (79 men and 143 women) occurred during the follow-up period (mean follow-up = 13 years). There was a statistically significant interaction between categories of body mass index and sex regarding ALS risk (p = 0.009): in men, a significant linear decrease of risk per unit of body mass index was observed (hazard ratio = 0.93, 95% confidence interval 0.86-0.99 per kg/m(2)); among women, the risk was more than 3-fold increased for underweight compared with normal-weight women. Among women, a significant risk reduction increasing the waist/hip ratio was also evident: women in the top quartile had less than half the risk of ALS compared with those in the bottom quartile (hazard ratio = 0.48, 95% confidence interval 0.25-0.93) with a borderline significant p value for trend across quartiles (p = 0.056). CONCLUSION: Increased prediagnostic body fat is associated with a decreased risk of ALS mortality.
Authors: Beatriz Cepeda-Valery; Gregg S Pressman; Vincent M Figueredo; Abel Romero-Corral Journal: Nat Rev Cardiol Date: 2011-01-25 Impact factor: 32.419
Authors: Valentina Gallo; H Bas Bueno-De-Mesquita; Roel Vermeulen; Peter M Andersen; Andreas Kyrozis; Jakob Linseisen; Rudolph Kaaks; Naomi E Allen; Andrew W Roddam; Hendriek C Boshuizen; Petra H Peeters; Domenico Palli; Amalia Mattiello; Sabina Sieri; Rosario Tumino; Juan-Manuel Jiménez-Martín; María José Tormo Díaz; Laudina Rodriguez Suarez; Antonia Trichopoulou; Antonio Agudo; Larraitz Arriola; Aurelio Barricante-Gurrea; Sheila Bingham; Kay-Tee Khaw; Jonas Manjer; Björn Lindkvist; Kim Overvad; Flemming W Bach; Anne Tjønneland; Anja Olsen; Manuela M Bergmann; Heiner Boeing; Francoise Clavel-Chapelon; Eiliv Lund; Göran Hallmans; Lefkos Middleton; Paolo Vineis; Elio Riboli Journal: Ann Neurol Date: 2009-04 Impact factor: 10.422
Authors: M Haftenberger; P H Lahmann; S Panico; C A Gonzalez; J C Seidell; H Boeing; M C Giurdanella; V Krogh; H B Bueno-de-Mesquita; P H M Peeters; G Skeie; A Hjartåker; M Rodriguez; J R Quirós; G Berglund; U Janlert; K T Khaw; E A Spencer; K Overvad; A Tjønneland; F Clavel-Chapelon; B Tehard; A B Miller; K Klipstein-Grobusch; V Benetou; G Kiriazi; E Riboli; N Slimani Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Daniela Mariosa; John D Beard; David M Umbach; Rino Bellocco; Jean Keller; Tracy L Peters; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Fang Fang; Freya Kamel Journal: Am J Epidemiol Date: 2017-03-01 Impact factor: 4.897
Authors: R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan Journal: J Neurol Date: 2014-06-24 Impact factor: 4.849
Authors: Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph Journal: J Neurol Date: 2015-01-25 Impact factor: 4.849
Authors: Marianthi-Anna Kioumourtzoglou; Ran S Rotem; Ryan M Seals; Ole Gredal; Johnni Hansen; Marc G Weisskopf Journal: JAMA Neurol Date: 2015-08 Impact factor: 18.302
Authors: Carlayne E Jackson; April L McVey; Stacy Rudnicki; Mazen M Dimachkie; Richard J Barohn Journal: Neurol Clin Date: 2015-11 Impact factor: 3.806
Authors: Éilis J O'Reilly; Kjetil Bjornevik; Michael A Schwarzschild; Marjorie L McCullough; Laurence N Kolonel; Loic Le Marchand; Joann E Manson; Alberto Ascherio Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2017-12-26 Impact factor: 4.092
Authors: Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz Journal: Lancet Date: 2014-02-28 Impact factor: 79.321